A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing

Autor: Raymond J. Pierce, Wolfgang Sippl, Julien Lancelot, Karin Schmidtkunz, Alokta Chakrabarti, Dina Robaa, Jelena Melesina, Tajith B. Shaik, Christophe Romier, Conrad V. Simoben, Manfred Jung, Srinivasaraghavan Kannan, Martin Marek
Přispěvatelé: Romier, Christophe, Martin-Luther-Universität Halle Wittenberg (MLU), Albert-Ludwigs-Universität Freiburg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), This work and the authors of this article received funding from the European Union’s Seventh Framework Programme for Research, Technological Development and Demonstration under Grant Agreements 241865 (SEtTReND) and 602080 (A-ParaDDisE). Further support was received by the Deutsche Forschungsgemeinschaft (Ju-295/13-1, SI-868/13-1). MM, TBS and CR are supported by institutional funds from the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Université de Strasbourg., The authors acknowledge the support and the use of resources of the French Infrastructure for Integrated Structural Biology FRISBI ANR-10-INBS-05 and of Instruct-ERIC. We wish to thank members of the ESRF-EMBL joint structural biology groups and the SOLEIL synchrotron for the use of their beamline facilities and for help during data collection. We are grateful to Pierre Legrand (SOLEIL) for his kind assistance for data processing, Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Pyrrolidines
MESH: Helminth Proteins/metabolism
MESH: Histone Deacetylases/metabolism
MESH: Histone Deacetylases/genetics
Pharmaceutical Science
MESH: Protein Structure
Secondary

Gene Expression
Apoptosis
Crystallography
X-Ray

Hydroxamic Acids
Molecular Docking Simulation
MESH: Helminth Proteins/antagonists & inhibitors
MESH: Chelating Agents/chemical synthesis
Protein Structure
Secondary

Analytical Chemistry
0302 clinical medicine
MESH: Structure-Activity Relationship
MESH: Hydroxamic Acids/chemical synthesis
Drug Discovery
MESH: Zinc/metabolism
MESH: Animals
[SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry
Molecular Biology/Biochemistry [q-bio.BM]

MESH: Histone Deacetylase Inhibitors/pharmacology
Chelating Agents
Anthelmintics
biology
Chemistry
MESH: Anthelmintics/pharmacology
Helminth Proteins
Schistosoma mansoni
epigenetics
crystal structure
docking
histone deacetylase (HDAC) inhibitors
schistosomiasis
virtual screening
MESH: Histone Deacetylases/chemistry
3. Good health
MESH: Schistosoma mansoni/drug effects
MESH: Pyrrolidines/pharmacology
Zinc
Biochemistry
Chemistry (miscellaneous)
Molecular Medicine
Protein Binding
MESH: Apoptosis/drug effects
MESH: Gene Expression
In silico
030231 tropical medicine
MESH: Zinc/chemistry
Article
Histone Deacetylases
lcsh:QD241-441
03 medical and health sciences
Structure-Activity Relationship
lcsh:Organic chemistry
MESH: Molecular Docking Simulation
Structure–activity relationship
MESH: Protein Binding
Animals
MESH: Helminth Proteins/genetics
Protein Interaction Domains and Motifs
Physical and Theoretical Chemistry
MESH: Histone Deacetylase Inhibitors/chemical synthesis
[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Biochemistry [q-bio.BM]

Virtual screening
MESH: Protein Interaction Domains and Motifs
Binding Sites
Organic Chemistry
MESH: Hydroxamic Acids/pharmacology
HDAC8
MESH: Schistosoma mansoni/growth & development
Epigenome
biology.organism_classification
MESH: Crystallography
X-Ray

MESH: Anthelmintics/chemical synthesis
Histone Deacetylase Inhibitors
030104 developmental biology
MESH: Binding Sites
Docking (molecular)
MESH: Chelating Agents/pharmacology
MESH: Schistosoma mansoni/enzymology
MESH: Helminth Proteins/chemistry
MESH: Schistosoma mansoni/genetics
MESH: Pyrrolidines/chemical synthesis
Zdroj: Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules
Molecules, 2018, 23 (3), pp.566. ⟨10.3390/molecules23030566⟩
Molecules, Vol 23, Iss 3, p 566 (2018)
Molecules; Volume 23; Issue 3; Pages: 566
Molecules, MDPI, 2018, 23 (3), pp.566. ⟨10.3390/molecules23030566⟩
ISSN: 1420-3049
DOI: 10.3390/molecules23030566⟩
Popis: International audience; A promising means in the search of new small molecules for the treatment of schistosomiasis (amongst other parasitic ailments) is by targeting the parasitic epigenome. In the present study, a docking based virtual screening procedure using the crystal structure of histone deacetylase 8 from Schistosoma mansoni (smHDAC8) was designed. From the developed screening protocol, we were able to identify eight novel N-(2,5-dioxopyrrolidin-3-yl)-n-alkylhydroxamate derivatives as smHDAC8 inhibitors with IC50 values ranging from 4.4-20.3 µM against smHDAC8. These newly identified inhibitors were further tested against human histone deacetylases (hsHDAC1, 6 and 8), and were found also to be exerting interesting activity against them. In silico prediction of the docking pose of the compounds was confirmed by the resolved crystal structure of one of the identified hits. This confirmed these compounds were able to chelate the catalytic zinc ion in a bidentate fashion, whilst showing an inverted binding mode of the hydroxamate group when compared to the reported smHDAC8/hydroxamates crystal structures. Therefore, they can be considered as new potential scaffold for the development of new smHDAC8 inhibitors by further investigation of their structure-activity relationship.
Databáze: OpenAIRE